| 000 | 01910 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515173033.0 | ||
| 264 | 0 | _c20091105 | |
| 008 | 200911s 0 0 eng d | ||
| 022 | _a1476-5586 | ||
| 024 | 7 |
_a10.1593/neo.81674 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHuch, Meritxell | |
| 245 | 0 | 0 |
_aUrokinase-type plasminogen activator receptor transcriptionally controlled adenoviruses eradicate pancreatic tumors and liver metastasis in mouse models. _h[electronic resource] |
| 260 |
_bNeoplasia (New York, N.Y.) _cJun 2009 |
||
| 300 |
_a518-28, 4 p following 528 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenoviridae _xgenetics |
| 650 | 0 | 4 |
_aAdenovirus E1A Proteins _xgenetics |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aCell Survival |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 |
_aGreen Fluorescent Proteins _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver _xmetabolism |
| 650 | 0 | 4 |
_aLiver Neoplasms, Experimental _xsecondary |
| 650 | 0 | 4 |
_aLuciferases _xgenetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aNIH 3T3 Cells |
| 650 | 0 | 4 |
_aOncolytic Virotherapy _xmethods |
| 650 | 0 | 4 |
_aOncolytic Viruses _xgenetics |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xpathology |
| 650 | 0 | 4 |
_aPromoter Regions, Genetic _xgenetics |
| 650 | 0 | 4 |
_aReceptors, Urokinase Plasminogen Activator _xgenetics |
| 650 | 0 | 4 | _aTumor Burden |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aGros, Alena | |
| 700 | 1 | _aJosé, Anabel | |
| 700 | 1 | _aGonzález, Juan Ramon | |
| 700 | 1 | _aAlemany, Ramon | |
| 700 | 1 | _aFillat, Cristina | |
| 773 | 0 |
_tNeoplasia (New York, N.Y.) _gvol. 11 _gno. 6 _gp. 518-28, 4 p following 528 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1593/neo.81674 _zAvailable from publisher's website |
| 999 |
_c18909057 _d18909057 |
||